ACM
NAGE

Aquatic Capital Management’s Niagen Bioscience NAGE Stock Holding History

Aquatic Capital Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
+31,733
New +$129K ﹤0.01% 1086
2026
Q1 		– Sell
-55,851
Closed -$355K – 1897
2025
Q4 		$355K Buy
+55,851
New +$389K 0.01% 838

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Aquatic Capital Management's NAGE Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Niagen Bioscience (NAGE) in Q2 2026: 31,733 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #1086 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in NAGE as recently as Q4 2025.

Aquatic Capital Management first reported a position in NAGE in Q4 2025 and has held it in 2 quarters since. The position peaked at $355K in Q4 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Aquatic Capital Management held 31,733 shares of Niagen Bioscience worth $101K as of Q2 2026.
  • Niagen Bioscience was a new Aquatic Capital Management position in Q2 2026.
  • Niagen Bioscience made up ﹤0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #1086 holding.
  • Aquatic Capital Management first reported a position in Niagen Bioscience in Q4 2025 and has held it in 2 quarters since.
  • Aquatic Capital Management's Niagen Bioscience position peaked at $355K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.